CAS 18356-28-0

Rolziracetam

Description:

Rolziracetam, with the CAS number 18356-28-0, is a member of the racetam family of compounds, which are known for their cognitive-enhancing properties. It is characterized by its structural similarity to piracetam, featuring a pyrrolidinone core. Rolziracetam is primarily recognized for its potential neuroprotective effects and its ability to enhance memory and learning processes. The compound is believed to modulate neurotransmitter systems, particularly by influencing glutamate and acetylcholine pathways, which are crucial for synaptic plasticity and cognitive function. Rolziracetam has been studied for its potential therapeutic applications in conditions such as cognitive impairment and neurodegenerative diseases. Its pharmacokinetics suggest good oral bioavailability, and it is typically administered in a non-toxic dosage range. However, as with many compounds in this class, further research is necessary to fully understand its efficacy, safety profile, and mechanism of action. Overall, Rolziracetam represents a compound of interest in the field of nootropics and cognitive enhancement.

Formula: C₇H₉NO₂

InChI: InChI=1S/C7H9NO2/c9-6-3-1-5-2-4-7(10)8(5)6/h5H,1-4H2

InChI key: InChIKey=IEZDOKQWPWZVQF-UHFFFAOYSA-N

SMILES: O=C1N2C(CCC2=O)CC1

Synonyms:

• 1-Azabicyclo[3.3.0]octane-2,8-dione
• 3H-Pyrrolizine-3,5(2H)-dione, tetrahydro-
• 3,5-Dioxopyrrolizidine
• Dihydro-1H-pyrrolizine-3,5(2H,6H)-dione
• 1H-Pyrrolizine-3,5(2H,6H)-dione, dihydro-

Rolziracetam

CAS: 18356-28-0

Rolziracetam

Purity: ≥95%

Molecular weight: 139.15g/mol

Ref: 54-BUP09144

Rolziracetam

CAS: 18356-28-0

Rolziracetam (CI-911) is a nootropic drug of the racetam family. It can improve short-term memory in rats and monkeys.

Formula: C₇H₉NO₂

Purity: 99.93%

Color and Shape: Solid

Molecular weight: 139.15

Ref: TM-T16783

Rolziracetam

CAS: 18356-28-0

Rolziracetam is a chemical substance that binds to the gamma-aminobutyric acid (GABA) receptor. It has been shown in clinical studies to be effective against epilepsy and can be used as an adjunct therapy for refractory focal epilepsies. Rolziracetam inhibits voltage-dependent calcium channels, which are responsible for the release of neurotransmitters at the synapse. Rolziracetam is also able to bind to GABA receptors, which may explain its therapeutic effects on epileptic seizures.

Formula: C₇H₉NO₂

Purity: Min. 95%

Molecular weight: 139.15 g/mol

Ref: 3D-TAA35628